New research shows patients can skip the dreaded colonoscopy without sacrificing protection from colorectal cancer.

Direct-mail human papillomavirus self-tests saved costs and were found to be effective for increasing screening rates.

Cleared by the FDA in 2024, the test gained real-world traction in 2025 when it was incorporated into a new global framework ...

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral ...

According to ABS data, it is women — even those who use health services more frequently overall — who are increasingly ...

September marked Cervical Cancer Awareness Month in South Africa. Research suggests that cervical cancer ranks as the fourth leading cancer type in the world for women. Most of the cervical cancer ...

A Nation at a Turning Point As September’s focus on prostate cancer gives way to October’s “Pink October” breast cancer ...

Consumers have testing options beyond the once-a-decade colonoscopy. But some doctors question Cologuard's testing program.

Cancer screenings are a vital part of a woman’s reproductive and overall health. While breast cancer is the most common reproductive cancer in women, cervical cancer is the third most common type of ...

THE march of AI now seems unstoppable in every part of our lives, from choosing the TV we watch to making our trains run on ...

Abstract: Cervical cancer is the fourth most prevalent cancer among women, with over 600,000 new cases and 300,000 deaths reported annually. While early detection through Pap smear screening ...